The CK reaction is coupled to the hexokinase (HK) and glucose-6-phosphate dehydrogenase (G6P-DH) catalyzed reaction sequence that measures ATP production by following the reduction of NADP at 340 nm (2). Oliver (1) recognized that adenylate kinase (AK; EC 2.7.4.3) also generated ATP in the presence of ADP (2 ADP -ATP + AMP) and would falsely elevate the apparent CK activity. Therefore, 10 mmol/liter of AMP was included in the incubation mixture to suppress the activity of AK. Several authors, including Oliver (1), have cautioned that the concentration of AMP is critical and that excess AMP will inhibit CK activity (1, 3, 4) . Others (5-7) have reported that AMP inhibits CK at AMP concentrations equal to or less than the concentration necessary to suppress AK. Kuby et al. (5) found that 4 mmol/liter of AMP caused about a 10% inhibition of CK activity. Hess et al. (6) showed a 14-34% inhibition at the AMP concentration used by Oliver (1) and has suggested the use of an AK activity blank in place of a single determination that includes use of AMP. Others (8) have determined that this dual-assay system is impractical for routine clinical analysis. In our own developmental work on an adaptation of the CK assay to a centrifugal analyzer, we found that AMP inhibits CK at the concentrations necessary to suppress AK activity. We have used a dual-assay system to measure both CK and AK activity and thus have evaluated the inhibitory effect of AMP on these activities. We have also evaluated several halides and an analog of AMP as possible specific inhibitors of AK. Results of this study have led to the development of a CK assay in which fluoride is used to inhibit AK.
Materials and Methods

CK and AK activities
were measured by a modification of the method of Hess et a!. (6) . The total activity of CK plus AK was measured by using both creatine phosphate and ADP as substrates (total assay). AK activity was measured by eliminating creatine phosphate from the reaction mixture (AK assay). CK activity was calculated by subtracting the AK activity from the of activity of these enzymes are based on methods described in Bergmeyer (9) . All other chemicals were of reagent grade or higher quality. Distilled de-ionized water was used throughout.
Serum samples with normal and increased CK activity were collected from leftover samples in the hospital clinical chemistry laboratory.
Samples were stored at 4 #{176}C and were assayed within 8 h of collection. Sera that showed visible hemolysis were not included in the study.
Results
Inhibition Studies with AMP
AK activity in patients' sera was measured in the presence of various concentrations of AMP. In the absence of AMP, serum AK activity ranged from 15-108 a -iv represent increasing concentrations of purified rabbit muscle CK.
Activities are the average of triplicate determinations.
a CK activities represent the average of triplicate determinations.
Serum CK activities in both the presence and absence of AMPwere corrected for AK activity.
U/liter (Figure 1 ). In the presence of AMP, AK activity was decreased in all sera. At 5 mmol of AMP per liter, activities ranged from 2-34 U/liter. At AMP concentrations of 10 and 15 mmol/liter, AK activity was less than 12 U/liter in all samples. To determine whether the measured activities were due to utilization of ADP by AK, we ran several control samples that did not contain ADP in the reaction mixtures.
In all cases, activities were negligible.
We then studied the effect of AMP concentration on serum CK activity.
Because sera may contain various amounts of AK activity in the presence of AMP ( Figure  1 ), AK activity corrections were made with all CK determinations.
We found that an increase in AMP concentration resulted in a decrease in CK activity ( Figure  2 ). Although the decreasing activity trend was seen in all sera, the degree of decrease was variable.
To determine whether serum components were involved in the AMP inhibition of CK, we performed studies on purified rabbit-muscle CK and found that it was also inhibited by AMP ( Table 2 ). The degree of purified CK inhibition was within the same range as human serum CK inhibition.
At 5, 10, and 15 mmol of AMP per liter, inhibition was 5-8%, 10-20%, and 13-24%, respectively.
It appeared that, at a constant AMP concentration, the samples with lower activity were inhibited more than the higher-activity samples. Such a relationship between CK activity and enzyme inhibition was not observed for 30 sera with activities ranging from 20 to 600 U/liter. A correlation study of serum CK activity in the absence of AMP (corrected for AK activity) and the percent inhibition of CK in the presence of 10 mmol/liter of AMP showed a correlation coefficient of only 0.374. The effect of ADP concentration on the AMP inhibition of CK was investigated.
In a representative experiment on purified CK from rabbit muscle arid serum CK, AMP inhibition of CK decreased with increasing ADP concentrations ( (Figure 3 ). The latter method was not corrected for remaining AK activity, in order to simulate the single determination method used routinely in many laboratories.
There was a good correlation (r = 0.994) between the two methods, but the slope (1.10) indicated that an average 10% lower activity was observed when the assay containing AMP was used.
An analog of adenosine 5'-monophosphate (AMP) was evaluated in a search for a more selective inhibitor of AK. Adenosine 2'-monophosphate, 10 mmol/liter, was substituted for AMP in the reaction mixture, and the inhibitory effect on both AK and CK was determined in three serum samples.
AK activity was inhibited by 19-28%; CK activity was also inhibited by 17-25%. Because of the inhibition of CK, further evaluation of this analog was not pursued.
Inhibition Studies with Fluoride
The inhibition of serum AK activity by increasing fluoride concentrations was studied (Figure 4) . Samples used were different from those used in the AMP studies, (Table 4) . Similar results were obtained when purified CK was used (Table 5) .
We compared CK activity as measured by the method employing art AK activity correction and by the method using 25 mmol of fluoride per liter, in 49 serum samples ( Figure 5 ). Activities measured in the assay containing fluoride were not corrected for any remaining AK activity. The results correlated well (r = 0.998), with a slope of 1.00.
We also compared results by our method, using 25 mmol of fluoride per liter, and by commercially available methods in which AMP is present to inhibit AK activity ( Figures   6 and 7) . Results with both the Worthington assay, which includes 3.7 mmol of AMP per liter, and the Calbiochem assay, which includes 9.5 mmol of AMP per liter, correlate well with our method. In comparison to the activities measured by the assay including fluoride, the Worthington and Calbiochem kits showed 38% and 50% lower activities, respectively. Because AK activity interferes with the CK assay that is based on ATP production, blank correction or inhibition of AK activity is required. AMP in concentrations ranging from 5 to 20 mmol/liter has been used by workers to inhibit AK during CK activity measurement (7, 12 Based on these studies, we conclude that CK activity can be accurately measured by use of either the blank correction method or by the method involving fluoride. The blank correction method requires two determinations and may be considered by many as impractical in the routine clinical laboratory.
The method with fluoride requires one determination and could easily be substituted for methods that now include AMP.
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